Bioactivity, hemocompatibility, and inflammatory response of calcium incorporated sulfonated polyether ether ketone on mouse-derived bone marrow cells.

Natural and synthetic polymeric materials, particularly soft and hard tissue replacements, are paramount in medicine. We prepared calcium-incorporated sulfonated polyether-ether ketone (SPEEK) polymer membranes for bone applications. The bioactivity was higher after 21 days of immersion in simulated body fluid (SBF) due to calcium concentration in the membrane. We present a new biomaterial healing system composed of calcium and sulfonated polyether ether ketone (Ca-SPEEK) that can function as a successful biomaterial without causing inflammation when tested on bone marrow cells. The Ca-SPEEK exhibited 13 ± 0.5% clot with low fibrin mesh formation compared to 21 ± 0.5% in SPEEK. In addition, the Ca-SPEEK showed higher protein adsorption than SPEEK membranes. As an inflammatory response, IL-1 and TNF-α in the case of Ca-SPEEK were lower than those for SPEEK. We found an early regulation of IL-10 in the case of Ca-SPEEK at 6 h, which may be attributed to the down-regulation of the inflammatory markers IL-1 and TNF-α. These results evidence the innovative bioactivity of Ca-SPEEK with low inflammatory response, opening venues for bone applications.

Flow electrode capacitive desalination of industrial RO reject.

Flow electrode capacitive deionization (FCDI) is a promising technology for efficiently treating industrial brine with high salt content. However, its desalination performance is currently limited by internal resistance. Achieving an effective FCDI system relies on active electrode materials with high conductivity. This study compares the desalination performances of the widely used flow electrode activated carbon (AC) with more conductive materials, reduced graphene oxide (rGO), and ZnO/rGO composite. Additionally, the lack of particle-to-particle contact in the flow electrode contributes to internal resistance and to address this, a cationic surface-active agent is introduced. This agent forms a stable dispersion, creating a space for enhanced mass loading of the active material. This modification enhances the conductive network and particle contact, reducing the diffusion path and promoting rapid ion transport. With a 5 wt% loading, ZnO/rGO achieved a 73% salt removal efficiency, surpassing AC at 63%. Furthermore, the surfactant-modified ZnO/rGO flow electrode with a 7 wt% loading demonstrated an 81% salt removal efficiency.

Ru/TiO2 Nanostructured Catalysts: Synthesis, Characterization and Catalytic Activity Towards Hydrogenation of Ethyl Levulinate.

Pristine TiO2 and x% Ru/TiO2 catalysts with different wt.% of Ru (x%= 1.5%, 2%, 2.5% and 3%) were synthesized using sol-gel and simple impregnation methods. Different characterization techniques such as X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), Scanning electron microscopy (SEM), High-resolution transmission electron microscope (HR-TEM), Inductively coupled plasma-optical emission spectrometry (ICP-OES) and Thermogravimetry/Differential thermal analysis (TG/DTA) were used to study the physicochemical and morphological properties. The XRD patterns of the as-prepared pristine TiO2 catalyst showed high crystalline nature. The HR-TEM images revealed that the Ru nanoparticles (NPs) were evenly dispersed on the TiO2 surface. The prepared catalysts were evaluated for their catalytic activity towards the liquid phase hydrogenation of ethyl levulinate under mild reaction conditions (ambient H2 pressure). Among the various catalysts, 2.5% Ru/TiO2 catalyst showed the maximum catalytic activity of 79% ethyl levulinate (EL) conversion with 82% selectivity of γ-valerolactone (GVL). The recyclability test revealed that the most active 2.5% Ru/TiO2 also showed the highest stability of the catalyst under optimized experimental conditions.

Degradation of Harmful Organics Using Visible Light Driven N-TiO2/rGO Nanocomposite.

Nitrogen doped titania over reduced form of graphene oxide (N-TiO2/rGO) catalysts were synthesized by adopting single step hydrothermal route. All the prepared photocatalysts were thoroughly characterized by using different analytical tools such as XRD, Raman, UV-DRS, FE-SEM and HRTEM. The photocatalytic activities of bare and composite catalysts were evaluated towards the photocatalytic decolourisation/degradation of Methylene blue dye (MB) and Metronidazole antibiotic (MTZ) under visible electromagnetic radiation. Among all the synthesized catalysts, N-TiO2/rGO composite catalyst showed the highest decolourisation/degradation activity towards both the dye and the antibiotic. The most active catalyst was also tested under UV and solar light irradiations which showed promising results. The stability of the most active catalyst (N-TiO2/rGO) was examined by recyclability test. The possible photocatalytic mechanism was proposed for the composite catalyst.

Characterization of antifungal metabolite phenazine from rice rhizosphere fluorescent pseudomonads (FPs) and their effect on sheath blight of rice.

We have shown, the outcome of antifungal activity of phenazine derivatives which is produced by fluorescent pseudomonads (FPs) for the control of sheath blight of rice. A total of 50 fluorescent pseudomonads (FPs) were isolated from rice rhizosphere. Off which, 36 FPs exhibited antagonistic activity against Rhizoctonia solani, Macrophomina phaseolina, Fusarium oxysporum, Alternaria alternata and Sclerotium rolfsii up to 70-80% compared to control by dual culture method. BOX-PCR analyses of antagonistic isolates indicated that two phylogenetic group, where group I consisted of 28 isolates and eight isolates belongs to group II. Among 36 FPs, a total of 10 FPs revealed that the presence of phenazine derivatives on thin layer chromatography (TLC), which is coincided with that of authentic phenazine with Rf value 0.57. Similar to TLC analysis, antibiotic encoding gene phenazine-1-carboxamide (PCN) was detected in 10 FPs by PCR analysis with respective primer. Among, PCN detected isolates of FPs, a significant biocontrol potential possessing isolate designated as VSMKU1 and it was showed prominent antifungal activity against R. solani and other tested fungal pathogens. Hence, the isolate VSMKU1 was selected for further studies. The selected isolate VSMKU1 was identified as Pseudomonas aeruginosa by 16S rDNA sequence analysis. The antifungal metabolite phenazine like compound produced by VSMKU1 was confirmed by UV, FT-IR and HPLC analysis. The phenazine compound from VSMKU1 significantly arrest the growth of R. solani compared to carbendazim by well diffusion method. The detached leaf assay showed remarkable inhibition of lesion height 80 to 85% by the treatments of culture (VSMKU1), cell free culure filtrate and phenazine like compound compared to control and other treatments was observed in detached leaves of rice. These results emphasized that VSMKU1 isolate can be used as an alternative potential biocontrol agent against sheath blight of rice, instead of using commercial fungicide such as validamycin and carbendazim which cause environmental pollution and health hazards.

Immuno-MALDI MS dataset for improved detection of HCVcoreAg in sera.

Complicated and large-scale challenge the contemporary biomedical community faces are development of highly-sensitive analytical methods for detection of protein markers associated with development of pathogenic mechanisms [2]. The atomic force microscopy (AFM) method in combination with specific fishing is unique among other analytical protein detection approaches; it allows visualization and counting of single protein molecules [3-6]. The present dataset focus on mass spectrometry method for detection of human hepatitis C virus core antigen (HCV core Ag) taking into account the potential modification with cations in blood serum samples, using mica chips for the atomic force microscopy (AFM-chips). To conduct specific protein fishing, we used flat AFM-chips preliminary sensibilized with molecular probes - aptamers, which are single-stranded DNA sequences. In our study we used four types of aptamers up to 85 nucleotides specific against the target protein - HCVcoreAg [3,4]. Working (n = 19) and control (n = 11) AFM-chips with aptamers were preliminarily immobilized on the surface in four zones and incubated in blood serum samples (See Supplementary fig. 1). Analysis of MS data regarding modification of marker protein peptides with Na+, K+, K2Cl+, and Na2Cl + ions enables to enhance the reliability of target proteins detection in the serum thereby demonstrating a high diagnostic potential.

Graphene oxide functionalized with chitosan based nanoparticles as a carrier of siRNA in regulating Bcl-2 expression on Saos-2 & MG-63 cancer cells and its inflammatory response on bone marrow derived cells from mice.

Presently, quite a lot of research that are being carried out to find a potential cure for cancer and many had made to clinical trial stage as well. In the present study, we focus on use of a novel graphene oxide functionalized chitosan nanoparticle targeting Saos-2 and MG-63 osteosarcoma cells. The graphene oxide chitosan nanoparticles were loaded with siRNA, studied for in vitro release with varying concentration & pH, and fitted to peppas model. MTT & ROS assay was used to evaluate biocompatibility of carrier and qPCR to study the inflammatory responses in particular checking gene expression of IL-6, TGF-ß, TNF-α in both RAW 264.7 and bone marrow derived macrophages. The results of study showed that release of siRNA were in a controlled fashion and effective at acidic pH that prevails on tumor site. The material was biocompatible and effective in case of Saos-2 osteosarcoma cells with a viability of 0.4 ±â€¯0.43 and 0.49 ±â€¯0.53 in case of MG-63 cells when treated with highest concentration of 100 µl siRNA compared to untreated cells that were in range of 0.64 ±â€¯0.67 in Saos-2 and 0.61 ±â€¯0.63 in MG-63 cells. The results of expression of inflammatory cytokines IL-6, TGF-ß & TNF-α showed negligible amount compared to control group serving the purpose of an effective carrier targeting tumor cells.